In a child with EBV‑associated post‑transplant lymphoproliferative disorder in remission who received IVIG for low IgG and now presents with fever, diarrhea, and brief episodic anal burning, what evaluation and management steps are recommended?

Evaluation and Management of Post-IVIG Fever, Diarrhea, and Anal Burning in a Child with EBV-PTLD in Remission

This child requires immediate evaluation to rule out PTLD relapse or new EBV disease, with urgent EBV viral load testing, physical examination for lymphadenopathy and organomegaly, and consideration of gastrointestinal endoscopy given the GI symptoms.

Immediate Diagnostic Workup

The presentation of fever and gastrointestinal symptoms (diarrhea, anal burning) in a child with prior EBV-PTLD history is concerning for potential PTLD relapse or EBV reactivation, even though the child is in remission for 1 year. Fever and gastrointestinal symptoms are recognized presentations of PTLD 1, and PTLD can present with localized GI involvement manifesting as mild diarrhea without systemic symptoms 2.

Essential Immediate Tests:

• Quantitative EBV DNA-emia by PCR (whole blood, plasma, or serum - all acceptable) 1. This is the highest priority test given the clinical context.

• Physical examination specifically assessing for:

  • Fever pattern and severity
  • Lymphadenopathy (cervical, axillary, inguinal)
  • Organomegaly (liver, spleen)
  • Tonsillar enlargement
  • Abdominal examination for masses 1

• Gastrointestinal endoscopy should be strongly considered given the diarrhea and anal symptoms. PTLD can present as localized colonic disease with only mild diarrhea and ulcerative lesions 2, and guidelines specifically recommend endoscopy for gastrointestinal symptoms 1.

• PET-CT/CT imaging to evaluate for nodal or extranodal disease 1

Critical Differential Considerations

1. PTLD Relapse or New EBV Disease

The combination of fever and GI symptoms in a patient with prior EBV-PTLD warrants high suspicion. PTLD commonly presents with fever and can involve the GI tract 1, 2. The anal burning could represent localized mucosal involvement.

2. IVIG-Related Complications

The temporal relationship to IVIG administration raises several possibilities:

• IVIG-associated fever and GI symptoms: Fever can occur with IVIG infusion 3
• Hypermetabolism from fever/infection shortens IgG half-life 3, which may be relevant to the clinical picture
• However, IVIG is NOT recommended for EBV prophylaxis or treatment 1, so its administration for low IgG should not be expected to prevent EBV complications

3. Infectious Gastroenteritis

The URTI admission and subsequent GI symptoms could represent a viral gastroenteritis, but this must be a diagnosis of exclusion given the PTLD history.

Management Algorithm

If EBV Viral Load is Significantly Elevated (>1,000-10,000 copies/mL):

1. Tissue biopsy is the gold standard for PTLD diagnosis if accessible lesions are identified 1. Given GI symptoms, colonoscopy with biopsy should be performed urgently.

2. Histological examination should include:

   • EBER in situ hybridization (high sensitivity and specificity) 1
   • Immunohistochemistry for viral antigens
   • Flow cytometry 1

3. If proven or probable PTLD:

   • First-line therapy: Rituximab 375 mg/m² once weekly (typically 1-4 doses) 1
   • Monitor EBV viral load weekly during treatment 1
   • Consider reduction of any ongoing immunosuppression if applicable 1

If EBV Viral Load is Moderately Elevated but No PTLD Confirmed:

• Pre-emptive therapy with rituximab should be initiated for significant EBV DNAemia without waiting for clinical disease progression 1
• Continue weekly EBV monitoring 1

If EBV Viral Load is Low/Negative:

• Pursue alternative diagnoses (infectious gastroenteritis, other causes of anal symptoms)
• Continue supportive care for URTI and GI symptoms
• Consider stool studies, bacterial cultures
• Local treatment for anal discomfort (topical anesthetics as already being used)

Critical Pitfalls to Avoid

1. Do not delay evaluation assuming symptoms are IVIG-related or simple gastroenteritis - the history of EBV-PTLD mandates aggressive workup

2. Do not rely on EBV viral load alone for PTLD diagnosis - tissue diagnosis is essential when feasible 1

3. Do not use antiviral drugs (acyclovir, ganciclovir) for EBV treatment or prophylaxis - they are ineffective against EBV 1

4. Do not assume remission for 1 year eliminates PTLD risk - late-onset PTLD can occur even decades after the initial event 4

5. Endoscopy should not be deferred - localized GI PTLD can present with minimal symptoms and requires direct visualization and biopsy 2

Symptomatic Management

For the anal burning specifically:

• Continue local anesthetic application as needed
• Ensure adequate hydration given diarrhea
• Consider barrier creams to protect perianal skin
• If infectious proctitis is identified, treat accordingly

Monitoring Strategy Going Forward

Given this child's high-risk history (EBV-PTLD post-chemotherapy), consider:

• Regular EBV DNA monitoring even in remission, particularly during intercurrent illnesses
• Lower threshold for imaging and endoscopy with any concerning symptoms
• Prompt evaluation of any fever, lymphadenopathy, or GI symptoms

The key principle is that fever and GI symptoms in a patient with prior EBV-PTLD require urgent evaluation to exclude relapse, as PTLD can be rapidly progressive and fatal if untreated 1.